 | • レポートコード：C-GIR20G2904 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「非小細胞肺がん治療薬の世界市場2019年」は、グローバルにおける非小細胞肺がん治療薬市場を展望するレポートです。非小細胞肺がん治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・非小細胞肺がん治療薬の市場概観 ・非小細胞肺がん治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・非小細胞肺がん治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・非小細胞肺がん治療薬の世界市場規模 ・非小細胞肺がん治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・非小細胞肺がん治療薬のアメリカ市場規模推移 ・非小細胞肺がん治療薬のカナダ市場規模推移 ・非小細胞肺がん治療薬のメキシコ市場規模推移 ・非小細胞肺がん治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・非小細胞肺がん治療薬のドイツ市場規模推移 ・非小細胞肺がん治療薬のイギリス市場規模推移 ・非小細胞肺がん治療薬のロシア市場規模推移 ・非小細胞肺がん治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・非小細胞肺がん治療薬の日本市場規模推移 ・非小細胞肺がん治療薬の中国市場規模推移 ・非小細胞肺がん治療薬の韓国市場規模推移 ・非小細胞肺がん治療薬のインド市場規模推移 ・非小細胞肺がん治療薬の東南アジア市場規模推移 ・非小細胞肺がん治療薬の南米市場分析（ブラジル、アルゼンチン等） ・非小細胞肺がん治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・非小細胞肺がん治療薬の種類別分析/販売量、売上、市場シェア（生物製剤、小分子標的療法、化学療法、その他） ・非小細胞肺がん治療薬の用途別分析/市場規模（肺腺がん、扁平上皮肺がん、大細胞肺がん） ・非小細胞肺がん治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・非小細胞肺がん治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Non-small Cell Lung Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-small Cell Lung Cancer Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Non-small Cell Lung Cancer Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-small Cell Lung Cancer Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
AstraZeneca
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Eli Lilly and Company
Merck & Co., Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biologics
Small Molecule Targeted Therapy
Chemotherapy
Other
Market Segment by Applications, can be divided into
Lung Adenocarcinoma
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
Table of Contents
1 Non-small Cell Lung Cancer Drugs Market Overview
1.1 Product Overview and Scope of Non-small Cell Lung Cancer Drugs
1.2 Classification of Non-small Cell Lung Cancer Drugs by Types
1.2.1 Global Non-small Cell Lung Cancer Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Types in 2018
1.2.3 Biologics
1.2.4 Small Molecule Targeted Therapy
1.2.5 Chemotherapy
1.2.6 Other
1.3 Global Non-small Cell Lung Cancer Drugs Market by Application
1.3.1 Global Non-small Cell Lung Cancer Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Lung Adenocarcinoma
1.3.3 Squamous Cell Lung Carcinoma
1.3.4 Large-cell Lung Carcinoma
1.4 Global Non-small Cell Lung Cancer Drugs Market by Regions
1.4.1 Global Non-small Cell Lung Cancer Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-small Cell Lung Cancer Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Non-small Cell Lung Cancer Drugs (2014-2024)
2 Company Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Non-small Cell Lung Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 F. Hoffmann-La Roche Ltd
2.2.1 Business Overview
2.2.2 Non-small Cell Lung Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bristol-Myers Squibb Company
2.3.1 Business Overview
2.3.2 Non-small Cell Lung Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eli Lilly and Company
2.4.1 Business Overview
2.4.2 Non-small Cell Lung Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck & Co., Inc.
2.5.1 Business Overview
2.5.2 Non-small Cell Lung Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Non-small Cell Lung Cancer Drugs Market Competition, by Players
3.1 Global Non-small Cell Lung Cancer Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-small Cell Lung Cancer Drugs Players Market Share
3.2.2 Top 10 Non-small Cell Lung Cancer Drugs Players Market Share
3.3 Market Competition Trend
4 Global Non-small Cell Lung Cancer Drugs Market Size by Regions
4.1 Global Non-small Cell Lung Cancer Drugs Revenue and Market Share by Regions
4.2 North America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
5 North America Non-small Cell Lung Cancer Drugs Revenue by Countries
5.1 North America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
5.2 USA Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
6 Europe Non-small Cell Lung Cancer Drugs Revenue by Countries
6.1 Europe Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
6.2 Germany Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
6.4 France Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue by Countries
7.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
7.2 China Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
7.5 India Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
8 South America Non-small Cell Lung Cancer Drugs Revenue by Countries
8.1 South America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
8.2 Brazil Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Non-small Cell Lung Cancer Drugs by Countries
9.1 Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
10 Global Non-small Cell Lung Cancer Drugs Market Segment by Type
10.1 Global Non-small Cell Lung Cancer Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Non-small Cell Lung Cancer Drugs Market Forecast by Type (2019-2024)
10.3 Biologics Revenue Growth Rate (2014-2024)
10.4 Small Molecule Targeted Therapy Revenue Growth Rate (2014-2024)
10.5 Chemotherapy Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Non-small Cell Lung Cancer Drugs Market Segment by Application
11.1 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application (2014-2019)
11.2 Non-small Cell Lung Cancer Drugs Market Forecast by Application (2019-2024)
11.3 Lung Adenocarcinoma Revenue Growth (2014-2019)
11.4 Squamous Cell Lung Carcinoma Revenue Growth (2014-2019)
11.5 Large-cell Lung Carcinoma Revenue Growth (2014-2019)
12 Global Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2024)
12.1 Global Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2024)
12.2 Global Non-small Cell Lung Cancer Drugs Market Forecast by Regions (2019-2024)
12.3 North America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
12.6 South America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Non-small Cell Lung Cancer Drugs Picture
Table Product Specifications of Non-small Cell Lung Cancer Drugs
Table Global Non-small Cell Lung Cancer Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Types in 2018
Figure Biologics Picture
Figure Small Molecule Targeted Therapy Picture
Figure Chemotherapy Picture
Figure Other Picture
Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Application (2014-2024)
Figure Non-small Cell Lung Cancer Drugs Revenue Market Share by Applications in 2018
Figure Lung Adenocarcinoma Picture
Figure Squamous Cell Lung Carcinoma Picture
Figure Large-cell Lung Carcinoma Picture
Table Global Market Non-small Cell Lung Cancer Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Non-small Cell Lung Cancer Drugs Type and Applications
Table AstraZeneca Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Type and Applications
Table F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Type and Applications
Table Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Non-small Cell Lung Cancer Drugs Type and Applications
Table Eli Lilly and Company Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Type and Applications
Table Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue Share by Players (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Players in 2017
Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Non-small Cell Lung Cancer Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Non-small Cell Lung Cancer Drugs Revenue Market Share in 2018
Figure Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Regions in 2018
Figure North America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure South America Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Table North America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
Table North America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018
Figure USA Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Europe Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018
Figure Germany Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure UK Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure France Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018
Figure China Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure India Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Table South America Non-small Cell Lung Cancer Drugs Revenue by Countries (2014-2019)
Table South America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018
Figure Brazil Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Non-small Cell Lung Cancer Drugs Revenue and Growth Rate (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue Share by Type (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Type (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Type in 2018
Table Global Non-small Cell Lung Cancer Drugs Revenue Forecast by Type (2019-2024)
Figure Global Non-small Cell Lung Cancer Drugs Market Share Forecast by Type (2019-2024)
Figure Global Biologics Revenue Growth Rate (2014-2019)
Figure Global Small Molecule Targeted Therapy Revenue Growth Rate (2014-2019)
Figure Global Chemotherapy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue by Application (2014-2019)
Table Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Share by Application in 2018
Table Global Non-small Cell Lung Cancer Drugs Revenue Forecast by Application (2019-2024)
Figure Global Non-small Cell Lung Cancer Drugs Market Share Forecast by Application (2019-2024)
Figure Global Lung Adenocarcinoma Revenue Growth Rate (2014-2019)
Figure Global Squamous Cell Lung Carcinoma Revenue Growth Rate (2014-2019)
Figure Global Large-cell Lung Carcinoma Revenue Growth Rate (2014-2019)
Figure Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Non-small Cell Lung Cancer Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Europe Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
Figure South America Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Non-small Cell Lung Cancer Drugs Revenue Market Forecast (2019-2024)
小細胞肺がん治療市場：世界及び中国市場分析・予測（～2024年） Small Cell Lung Cancer Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Small Cell Lung Cancer Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Smal…- 扁平上皮非小細胞肺がん治療法市場：世界及び中国市場分析・予測（～2024年） Squamous Non-Small Cell Lung Cancer Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Squamous Non-Small Cell Lung Cancer Therapeutics industry with a focus on the Chinese market. The report provides key statistics …
- 世界の腫瘍学小分子薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…
- 食道がん治療薬の世界市場 2019年版：種類別（フルオロウラシル、シスプラチン、ドセタキセル、カルボプラチン、その他）、用途別（標的療法、化学療法） Scope of the Report: The global Esophageal Cancer Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
- 肺がん手術市場：世界及び中国市場分析・予測（～2024年） Lung Cancer Surgery Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Lung Cancer Surgery industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lung Cancer Surgery manufactur…